These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1700225)

  • 1. Comparison of the effects of intravenous LNC-834, a new antiarrhythmic agent, and quinidine in canine models of arrhythmia.
    D'Alonzo AJ; Butterfield JL; Drexler AP; Sergio SL
    J Cardiovasc Pharmacol; 1990 Sep; 16(3):506-17. PubMed ID: 1700225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of bepridil, verapamil, and quinidine in the prevention of ventricular tachycardia induced by programmed electrical stimulation in the digitalized dog.
    Keren G; Tepper D; Butler B; Torres V; Somberg JC
    Am Heart J; 1984 Nov; 108(5):1236-43. PubMed ID: 6333809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of inducible ventricular arrhythmias by intravenous azimilide in dogs with previous myocardial infarction.
    Drexler AP; Micklas JM; Brooks RR
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):848-55. PubMed ID: 8961084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Quinidine in the Pharmacological Therapy of Ventricular Arrhythmias 'Quinidine'.
    Bozic B; Uzelac TV; Kezic A; Bajcetic M
    Mini Rev Med Chem; 2018; 18(6):468-475. PubMed ID: 28685701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinidine revisited.
    Yang F; Hanon S; Lam P; Schweitzer P
    Am J Med; 2009 Apr; 122(4):317-21. PubMed ID: 19249010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinidine-Responsive Polymorphic Ventricular Tachycardia in Patients With Coronary Heart Disease.
    Viskin S; Chorin E; Viskin D; Hochstadt A; Halkin A; Tovia-Brodie O; Lee JK; Asher E; Laish-Farkash A; Amit G; Havakuk O; Belhassen B; Rosso R
    Circulation; 2019 May; 139(20):2304-2314. PubMed ID: 30696267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinidine-A legacy within the modern era of antiarrhythmic therapy.
    Vitali Serdoz L; Rittger H; Furlanello F; Bastian D
    Pharmacol Res; 2019 Jun; 144():257-263. PubMed ID: 31026503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidysrhythmic actions of meobentine sulfate.
    Zimmerman JM; Patterson E; Pitt B; Lucchesi B
    Am Heart J; 1984 Jun; 107(6):1117-24. PubMed ID: 6720538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meobentine sulfate: antiarrhythmic and electrophysiologic effects assessed by programmed electrical stimulation and ambulatory monitoring in patients with complex ventricular tachyarrhythmia. Report of a multicenter evaluation.
    Anderson JL; Reid PR; Platia EV; Akhtar M; Ruskin JN; Schaal SF; Jueng P; Long RA; Wenger TL
    Am Heart J; 1985 Oct; 110(4):774-84. PubMed ID: 3901715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dofetilide, a class III antiarrhythmic drug, on various ventricular arrhythmias in dogs.
    Chen J; Xue Y; Eto K; Ni C; Hashimoto K
    J Cardiovasc Pharmacol; 1996 Oct; 28(4):576-84. PubMed ID: 8891885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dofetilide on electrical dispersion and arrhythmias in post-infarcted anesthetized dogs.
    D'Alonzo AJ; Sewter JC; Darbenzio RB; Hess TA
    Basic Res Cardiol; 1995; 90(5):424-34. PubMed ID: 8585865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective comparison of intravenous quinidine and intravenous procainamide in patients undergoing electrophysiologic testing.
    Holzberger PT; Greenberg ML; Paicopolis MC; Ozahowski TP; Ho PC; O'Connor GT
    Am Heart J; 1998 Jul; 136(1):49-56. PubMed ID: 9665218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lidocaine has a narrow antiarrhythmic dose range against ventricular arrhythmias induced by programmed electrical stimulation in conscious postinfarction dogs.
    Krejcy K; Krumpl G; Todt H; Raberger G
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):213-8. PubMed ID: 1448183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lidocaine (Xylocaine) as an anti-arrhythmic agent.
    Med Lett Drugs Ther; 1971 Jan; 13(1):1-2. PubMed ID: 4104507
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiarrhythmic effects of MS-551, a new class III antiarrhythmic agent, on canine models of ventricular arrhythmia.
    Kamiya J; Ishii M; Katakami T
    Jpn J Pharmacol; 1992 Feb; 58(2):107-15. PubMed ID: 1507517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lorcainide. A comparative trial with quinidine gluconate in patients with previously untreated ventricular arrhythmias.
    Falk RH; O'Brien JL
    Chest; 1984 Oct; 86(4):537-40. PubMed ID: 6383741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guanfu base A inhibit the post-infarction ventricular arrhythmias in dogs].
    Wang YQ; Su L; Gong GQ; Liu JH
    Yao Xue Xue Bao; 1994; 29(2):141-4. PubMed ID: 8042512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of MS-551, a new class III antiarrhythmic drug, on programmed stimulation-induced ventricular arrhythmias, electrophysiology, and hemodynamics in a canine myocardial infarction model.
    Kondoh K; Hashimoto H; Nishiyama H; Umemura K; Ozaki T; Uematsu T; Nakashima M
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):674-80. PubMed ID: 7516022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiarrhythmic actions of intravenous and oral UM424 in postinfarction canine myocardium.
    Gibson JK; Patterson E; Lucchesi BR
    J Cardiovasc Pharmacol; 1985; 7(2):211-8. PubMed ID: 2581070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.